Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$11.69 USD
-0.07 (-0.60%)
Updated Oct 25, 2024 04:00 PM ET
After-Market: $11.68 -0.01 (-0.09%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $0.08 | 6.67% |
Earnings Summary
For their last quarter, Amicus Therapeutics (FOLD) reported earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This reflects a positive earnings surprise of 100.00%. Look out for FOLD's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $0.08 per share, reflecting a year-over-year increase of 214.29%.
Earnings History
Price & Consensus
Zacks News for FOLD
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma
FOLD: What are Zacks experts saying now?
Zacks Private Portfolio Services